Ani Pharmaceuticals (ANIP) Revenue (2009 - 2026)
Ani Pharmaceuticals (ANIP) recorded Revenue of $290.78 million in Q3 2026, up 27.6% from $227.81 million a year earlier and up 9.3% from the prior quarter.
Ani Pharmaceuticals (ANIP) Revenue (2009 - 2026) Analysis & Trends
On a TTM basis, Ani Pharmaceuticals' Revenue came in at $1.04 billion as of Sep 30, 2026, up 25.9% year-over-year; for FY2025, it came in at $883.37 million, up 43.8% from FY2024.
- Annual Revenue has increased for 13 straight years, with a five-year compound annual growth rate of 33.5% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $614.38 million in FY2024 (+26.2%), $486.82 million in FY2023 (+53.9%), $316.39 million in FY2022 (+46.4%) and $216.14 million in FY2021 (+3.7%).
- The Q3 2026 figure is the highest quarterly Revenue in data going back to Q1 2009.
- On a year-over-year basis, Revenue has increased for 20 consecutive quarters, with growth averaging 37.3% over the last eight quarters.
- The year-over-year growth in Revenue has ranged between 6.4% (Q4 2021) and 65.6% (Q1 2023) over the last five years.
- Per Business Quant, the preceding three quarters came in at $266.04 million (Q2 2026), $237.46 million (Q1 2026) and $247.06 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.98 Bn | 1,260.60 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 685.09 Bn | 604.95 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 523.41 Bn | 491.42 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 361.33 Bn | 324.27 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 312.92 Bn | 286.15 Bn | - | - |
| 6 | Astrazeneca | 286.64 Bn | 260.16 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 252.19 Bn | 203.84 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 209.51 Bn | 184.62 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 165.21 Bn | 112.57 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Ani Pharmaceuticals | 1.51 Bn | 127.47 Mn | 179.25 Mn | 290.78 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 290.78 Mn |
| Jun 30, 2026 | 266.04 Mn |
| Mar 31, 2026 | 237.46 Mn |
| Dec 31, 2025 | 247.06 Mn |
| Sep 30, 2025 | 227.81 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 197.12 Mn |
| Dec 31, 2024 | 190.57 Mn |
| Sep 30, 2024 | 148.33 Mn |
| Jun 30, 2024 | 138.04 Mn |
| Mar 31, 2024 | 137.43 Mn |
| Dec 31, 2023 | 131.65 Mn |
| Sep 30, 2023 | 131.83 Mn |
| Jun 30, 2023 | 116.55 Mn |
| Mar 31, 2023 | 106.79 Mn |
| Dec 31, 2022 | 94.23 Mn |
| Sep 30, 2022 | 83.82 Mn |
| Jun 30, 2022 | 73.86 Mn |
| Mar 31, 2022 | 64.48 Mn |
| Dec 31, 2021 | 60.93 Mn |
Ani Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();